Results 221 to 230 of about 73,182 (252)
Some of the next articles are maybe not open access.

Markers for Anti-cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma

2013
Therapeutic strategies that block Cytotoxic T lymphocyte antigen-4 (CTLA-4) enhance antitumor immunity and prolong the lives of patients with metastatic melanoma. However, only a subset of patients benefit, and responses are often delayed due to heterogeneous response kinetics.
Michael A, Postow   +4 more
openaire   +2 more sources

CTLA-4-dependent trogocytosis promotes the interactions between Tregs and antigen-presenting cells

The Journal of Immunology, 2020
Abstract Regulatory T cells (Tregs) are responsible for the maintenance of immune homeostasis. They express the coinhibitory receptor CTLA-4 in high quantities, whose loss causes severe systemic autoinflammation in both mice and humans.
Murat Tekguc   +4 more
openaire   +1 more source

Identification of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) isoforms in the Pekin duck

Developmental & Comparative Immunology, 2010
Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4, CD152) is an inhibitory T cell receptor predominately expressed on activated T cells. The duck CTLA-4 (DuCTLA-4) cDNA and a transcript lacking the predicted transmembrane encoding region (DuCTLA-4DeltaTM) were isolated from splenocytes using RT-PCR.
Qingxia, Yao   +6 more
openaire   +2 more sources

The Role of CD28 and Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) in Regulatory T-Cell Biology

Immunological Reviews, 2006
Summary:  The profound influence of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) on T‐cell immunity has been known for over a decade, yet the precise roles played by these molecules still continue to emerge. Initially viewed as molecules that provide cell‐intrinsic costimulatory and inhibitory signals, recent evidence suggests that both CD28 and ...
Lucy Walker, David M Sansom
exaly   +3 more sources

Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Gene Polymorphism and Susceptibility to Non-Hodgkin's Lymphoma

American Journal of Hematology, 2004
AbstractThe CTLA‐4 molecule plays an important role in immune regulation by downregulating activation of T cells. Polymorphisms in the CTLA‐4 gene have been shown to be associated to a number of autoimmune diseases including blood disorders. In this study, the intragenic polymorphisms of the CTLA‐4 gene at position −318*C/T, +49*A/G, and the ...
Giovanna Piras   +2 more
exaly   +3 more sources

Evaluation of cytotoxic T- lymphocyte antigen-4 (CTLA-4) polymorphisms and soluble CTLA-4 (sCTLA-4) in chronic hepatitis B virus infection

Annals of Tropical Medicine & Public Health, 2021
Yasmin S. Mahdi   +2 more
openaire   +1 more source

Critical Care Management of Chimeric Antigen Receptor T-Cell Therapy Recipients

Ca-A Cancer Journal for Clinicians, 2022
Sandrine Valadè   +2 more
exaly  

Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus.

Clinical and experimental rheumatology, 2000
Genetic susceptibility to systemic lupus erythematosus (SLE) is conferred not only by various genes within the major histocompatibility complex (MHC) region, but also by several other non-MHC linked genes. The negatively signalling molecule CTLA-4 is involved in establishing and maintaining of peripheral T cell tolerance, which controls T cell ...
R, Pullmann   +8 more
openaire   +1 more source

A Review of Cancer Immunotherapy Toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Home - About - Disclaimer - Privacy